Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Process Validation with Qualification Training Course" conference has been added to ResearchAndMarkets.com's offering.
Attending this invaluable two-day event will give you the tools to fully understand and comply with current EU and FDA process validation guidelines and meet implementation challenges.
Taking a practical and analytical approach to process design, equipment and utility qualification, the programme will link product requirements to equipment verification and commercial-scale process validation.
Good engineering practice (GEP) and a range of techniques, including quality risk management and design of experiments
and statistics, will be examined to optimise continual improvement in process qualification, verification, commissioning and validation.
Benefits of attending:
- Know the scope of FDA, EU and other international validation guidelines
- Establish a three-stage, science and risk-based, life cycle process validation programme that can be applied to all products internationally, from generic products to novel medicines to ATMPs
- Clarify similarities and differences between EU and US regulatory expectations
- Understand the importance of a science and risk-based approach to support process validation and qualification
- Realise significant business benefits by clarifying the key purposes of validation
- Reduce validation documentation by concentrating on product drivers supported by clear qualification steps
- Unscramble the real meaning of buzzwords such as qualification, verification and validation
- Learn tools and techniques for you to subsequently apply to your products
Certification:
- CPD: 12 hours for your records
- Certificate of completion
Who Should Attend?
This seminar will be of particular interest to all those from the pharmaceutical industry working in:
- Development
- Manufacturing
- Engineering
- Quality
It will also benefit the following personnel working in the pharmaceutical and biopharmaceutical industry:
- Process engineers
- Pharmacists
- Scientists
- Quality assurance professionals
- Quality control managers
- Late-stage product and process development engineers, scientists, pharmacists
- Technology scale-up and transfer managers
- Validation and qualification managers
- Validation and qualification specialists
- Risk management specialists
- Lean management specialists
- Operations managers and engineers
Key Topics Covered
Day 1
- The science and risk-based approach to process validation
- ICH Q8/9/10/11/12
- Exercise 1 - Key points
- Introduction to the FDA process validation guidance
- Introduction to the EU Process Validation Guidelines and Annex 15
- Exercise 2: Guidance
- Process design: FDA PV Stage 1
- Exercise 3: Process Design
- Quality risk management
- Exercise 4: Risk assessment
Day 2
- Equipment and utility qualification: FDA PV Stage 2.1
- Exercise 5: Equipment Qualification
- Tools for Process Validation - part 1
- Tools for Process Validation - part 2
- Exercise 6: What techniques/tools to use at which PV Stage
- Process Performance Qualification/Process Validation - FDA PV Stage 2.2
- Exercise 7: Process Validation - number of batches
- Continued Process Verification/Ongoing Process Verification - FDA PV Stage 3
- Exercise 8: Ongoing Process Verification
- Case Study: Process improvement
- Exercise 9: Continual Improvement
- Exercise 10: SWOT
For more information about this conference visit https://www.researchandmarkets.com/r/s4ek57
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
